AOD-9604 — Wolverine Health

How it works

A fragment of the C-terminal region of human growth hormone, designed to replicate the fat-metabolising activity of hGH without the growth-promoting or insulin-sensitising effects. Phase II/III trials for obesity ran in the early 2000s; primary efficacy endpoints weren't met at meaningful effect sizes. It received Generally Recognized as Safe (GRAS) status from the FDA for food use in 2014 — a distinct regulatory track from drug approval. On the PCAC July 2026 docket.

FDA status: No FDA drug approval. FDA GRAS status for food use (2014). Under PCAC July 23–24 2026 review for potential 503A bulk substance listing.
WADA status: Not applicable
Route: subcutaneous injection; oral (trials)

Key studies

AOD-9604: metabolic effects of a fragment of human growth hormone — Heffernan et al.

AOD-9604 (hGH frag 177-191) reduces body weight and fat mass in obese rodents without affecting growth or IGF-1 levels, suggesting a selective lipolytic mechanism distinct from full-length hGH.

Wolverine Health is building physician-supervised peptide protocols. Get early access.

Join the waitlist

Research on AOD-9604

503B outsourcing pharmacies and compounded peptides: the regulatory gap that still matters

Section 503B outsourcing facilities are the higher-volume, FDA-inspected cousin of the corner compounding pharmacy. The 503B Bulks List is its own regulatory pipeline — and it changes what an actual peptide supply chain looks like when one opens.

AOD-9604 and adiponectin: the fat-loss signal that skips growth hormone

WADA

Most fat-loss peptides work by turning up your whole growth-hormone system and hoping the fat follows. AOD-9604 skips that and talks to the fat cell directly — a cleaner idea. Here is how the mechanism works, why your fat is a hormone-producing organ, and how far the human proof actually goes.

AOD-9604: growth hormone's fat-burning half, on its own

WADA

AOD-9604 is the cleanest idea on the peptide menu — the fat-burning part of growth hormone, without everything else it drags along. Animal data delivered, and in the GLP-1 era a fat-burner that spares muscle is what the moment wants. Here's what it could do for you, and how far the proof goes.